mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.02 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.2 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.008 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
-0.19 |
7e-09 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.2 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.3 |